KR20040026273A - The health-supporting food being effective the dementia and its preparation method - Google Patents
The health-supporting food being effective the dementia and its preparation method Download PDFInfo
- Publication number
- KR20040026273A KR20040026273A KR1020020057658A KR20020057658A KR20040026273A KR 20040026273 A KR20040026273 A KR 20040026273A KR 1020020057658 A KR1020020057658 A KR 1020020057658A KR 20020057658 A KR20020057658 A KR 20020057658A KR 20040026273 A KR20040026273 A KR 20040026273A
- Authority
- KR
- South Korea
- Prior art keywords
- dementia
- weight
- water
- deep water
- germanium
- Prior art date
Links
- 206010012289 Dementia Diseases 0.000 title abstract description 33
- 235000013305 food Nutrition 0.000 title abstract description 13
- 238000002360 preparation method Methods 0.000 title 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims abstract description 39
- 229910052732 germanium Inorganic materials 0.000 claims abstract description 30
- 239000000843 powder Substances 0.000 claims abstract description 12
- 239000013535 sea water Substances 0.000 claims abstract description 11
- 241000255789 Bombyx mori Species 0.000 claims abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 63
- 244000163122 Curcuma domestica Species 0.000 claims description 9
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 9
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 9
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 9
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 9
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 9
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 9
- 235000003373 curcuma longa Nutrition 0.000 claims description 9
- 210000004207 dermis Anatomy 0.000 claims description 9
- 235000008397 ginger Nutrition 0.000 claims description 9
- 229940010454 licorice Drugs 0.000 claims description 9
- 239000010865 sewage Substances 0.000 claims description 9
- 235000013976 turmeric Nutrition 0.000 claims description 9
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 8
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 8
- 244000082204 Phyllostachys viridis Species 0.000 claims description 8
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 8
- 239000011425 bamboo Substances 0.000 claims description 8
- 241000675108 Citrus tangerina Species 0.000 claims description 5
- 244000273928 Zingiber officinale Species 0.000 claims description 2
- 238000011282 treatment Methods 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 12
- 239000012676 herbal extract Substances 0.000 abstract description 8
- 230000002265 prevention Effects 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 238000002156 mixing Methods 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 3
- 235000008599 Poria cocos Nutrition 0.000 abstract 2
- 241001619444 Wolfiporia cocos Species 0.000 abstract 2
- 239000010268 Acori graminei Rhizoma Substances 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 20
- 235000015872 dietary supplement Nutrition 0.000 description 16
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 15
- 239000001301 oxygen Substances 0.000 description 15
- 229910052760 oxygen Inorganic materials 0.000 description 15
- 238000012360 testing method Methods 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 241000411851 herbal medicine Species 0.000 description 8
- 239000001257 hydrogen Substances 0.000 description 8
- 229910052739 hydrogen Inorganic materials 0.000 description 8
- 206010027175 memory impairment Diseases 0.000 description 8
- 241000234314 Zingiber Species 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000003449 preventive effect Effects 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 238000009395 breeding Methods 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- -1 hydrogen ions Chemical class 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000011573 trace mineral Substances 0.000 description 5
- 235000013619 trace mineral Nutrition 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 230000002490 cerebral effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 3
- 238000011047 acute toxicity test Methods 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 210000001652 frontal lobe Anatomy 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- IQULGZQMMPRBLA-UHFFFAOYSA-N 2-carboxyethylgermanium Chemical compound OC(=O)CC[Ge] IQULGZQMMPRBLA-UHFFFAOYSA-N 0.000 description 2
- 206010054196 Affect lability Diseases 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 208000036626 Mental retardation Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- 206010034719 Personality change Diseases 0.000 description 2
- 240000002299 Symphytum officinale Species 0.000 description 2
- 235000005865 Symphytum officinale Nutrition 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 125000000082 organogermanium group Chemical group 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 201000000980 schizophrenia Diseases 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- IRJCBFDCFXCWGO-SCSAIBSYSA-N (2r)-2-azaniumyl-2-(3-oxo-1,2-oxazol-5-yl)acetate Chemical compound [O-]C(=O)[C@H]([NH3+])C1=CC(=O)NO1 IRJCBFDCFXCWGO-SCSAIBSYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 208000024806 Brain atrophy Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 208000018152 Cerebral disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010010305 Confusional state Diseases 0.000 description 1
- 208000022540 Consciousness disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- IRJCBFDCFXCWGO-UHFFFAOYSA-N Ibotenic acid Natural products OC(=O)C(N)C1=CC(=O)NO1 IRJCBFDCFXCWGO-UHFFFAOYSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010051602 Laziness Diseases 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010037180 Psychiatric symptoms Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000011646 bottled functional water Nutrition 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 230000008344 brain blood flow Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 230000002920 convulsive effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000012851 eutrophication Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 235000020680 filtered tap water Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000003923 mental ability Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 210000001259 mesencephalon Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 210000002682 neurofibrillary tangle Anatomy 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 210000001152 parietal lobe Anatomy 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000012046 side dish Nutrition 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 210000003478 temporal lobe Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000048 toxicity data Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000011882 ultra-fine particle Substances 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
Abstract
Description
본 발명은 정제된 심층수(선도액), 유기 게르마늄(Ge-132) 및 한약재를 주재료로 하여 치매에 우수한 치료 및 예방 효과를 나타내는 건강보조식품 및 이의 제조 방법에 관한 것으로, 좀 더 구체적으로는 해저 600m의 심층수와 1400m의 심층수를 정제하여 적정한 비율로 혼합한 정제된 심층수(선도액) 60 ∼ 74.5중량%, 하수오, 진피, 탱자열매, 생강, 울금, 복령, 죽엽, 천마, 누에분말, 석창포 및 감초로 구성되는 한약재 추출물 25 ∼ 39.5중량% 및 유기 게르마늄(Ge-132) 0.5 ∼ 15중량%로 구성되는 것을 특징으로 하는 치매에 우수한 치료 및 예방 효과를 갖는 건강보조식품 및 이의 제조방법에 관한 것이다.The present invention relates to a dietary supplement and a method for producing the same, which are excellent in treating and preventing dementia, based on purified deep water (freshness solution), organic germanium (Ge-132), and herbal medicines. 60 to 74.5% by weight of purified deep water (lead solution), sewage, dermis, tangerine, ginger, turmeric, bokyeong, bamboo leaf, cheonma, silkworm powder, Seokchangpo and 600m deep water and 1400m deep water. The present invention relates to a health supplement having excellent therapeutic and preventive effects on dementia, and a method for manufacturing the same, comprising 25 to 39.5 wt% of herbal extracts composed of licorice and 0.5 to 15 wt% of organic germanium (Ge-132). .
치매란 지능, 의지, 기억 등 정신적인 능력이 현저하게 감퇴한 것으로서, 정신지체(精神遲滯)와 마찬가지로 지능의 장애인데, 정신지체는 주로 지능의 발육이 늦거나 정지된 것인데 대하여, 치매는 병전에는 정상적이던 지능이 대뇌의 질환 때문에 저하된 것을 말한다. 치매의 전형적인 것은 대뇌신경세포의 광범위한 손상이며 기질(器質)치매라고 하며, 그 밖에 노인치매, 매독에 의한 진행마비 또는 간질대발작의 반복으로 일어나는 간질치매 등이 있다.Dementia is a marked decline in mental abilities such as intelligence, will, and memory. Like mental retardation, dementia is a disorder of intelligence, and mental retardation is mainly due to late or stopped development of intelligence. Normal intelligence is degraded due to cerebral diseases. Typical of dementia is widespread damage of cerebral nerve cells and is called dementia. Others include elderly dementia, progressive paralysis caused by syphilis, or epilepsy dementia caused by repeated epileptic seizures.
기억 및 이해의 장애, 계산 능력의 저하, 사고의 빈곤화, 보속(保續:일정한 언동을 실현하는 충동이 존속하여 같은 언동을 되풀이 하는 현상)의 경향 등도 볼 수 있고, 다시 감정적인 장애를 수반하며 정동(情動)의 불안정이나 제어가 곤란하게 되는 정동실금(情動失禁) 등도 볼 수 있고 성숙한 정성(情性)도 침해되는 것이 보통이며, 당연히 심적인 시야도 좁아지고, 치매가 심해지면 동물적 생활에 빠지는 일도 있고, 정신분열증에서는 얼핏 보아 치매와 같이 보이면서 개개의 기본적 지능은 잘 유지되는 일이 많아 치매라고 하지 않지만, 말기에는 치매와 구별할 수 없거나 당연히 치매라고 해야 할 상태가 되는 것이 있다.Impaired memory and understanding, poor computational ability, poor poverty of thought, and the tendency of retaliation, a phenomenon in which the impulse to realize a constant behavior persists and repeats the same behavior. Instability of emotions and emotional incontinence, which can be difficult to control, can also be seen. Mature emotionality is also violated. Of course, mental vision becomes narrower, and dementia deepens into animal life. At first glance, schizophrenia looks like dementia at first glance, and individual basic intelligence is often well maintained, but dementia is indistinguishable from dementia or dementia.
대뇌의 손상이 국한성인 때는 나타나지 않고 그 부위에 대응한 국소적인 소(巢)증세, 즉 전두엽의 자발성 결여, 운동성 실어, 성격변화, 두정엽(頭頂葉)의 실행(失行), 실인(失認), 후두엽의 시각 실어, 측두엽의 감각성 실어 등이 나타난다.It does not appear when the damage to the cerebral region is localized, but local microscopic symptoms corresponding to the site, ie, spontaneous lack of frontal lobe, motility aspiration, personality change, execution of parietal lobe, and perception ), Visual laryngeal lobe, and temporal lobe sensory laryngeal lobe.
노인성치매는 노화(老化)에 따른 뇌(腦)의 퇴행성 변화의 결과 나타나는 노년성 정신장애로서, 주로 지능의 기능저하로 일어나는데, 65세 전후부터 70세의 노년기에 일어나는 경우를 말한다. 생리적인 노망(老妄)으로의 이행에 대해서는 현상적으로 명확한 구별을 할 수 없다.Geriatric dementia is an age-related mental disorder that results from degenerative changes in the brain due to aging. It is mainly caused by the deterioration of intelligence. There is no phenomenal clear distinction about the transition to physiological senility.
노인성 변화로는 육안으로는 특히, 전두엽(前頭葉)에서 현저한 뇌의 위축을 볼 수 있으며, 조직학적으로는 신경세포의 감소, 신경세포 내의 리보프스틴 증가, 노인반점의 출현, 신경원섬유(神經原纖維)의 비후(肥厚) 등을 들 수 있고, 증세로는 심한 건망증과 기억장애로 시작하여 그런 장애를 얼버무리기 위한 당혹작화(當惑作話) 또는 지각저하(知覺低下)가 생기고, 사고면에서는 군소리를 늘어놓는 우원증(迂遠症)이나 의욕만 앞서는 보속증(保續症)이 나타나며, 판단력이나 추리력이 저하되고, 생산적 사고가 소실되며, 계산력이 쇠퇴하고, 사태에 대한 판단이 불가능해지는 등의 증세가 나타난다.The senile changes can be seen in the frontal lobe, especially in the frontal lobe, with significant brain atrophy. Histologically, neuronal degeneration, increased ribovstin in neurons, the appearance of senile plaques, and neurofibrillary tangles. Thickening of 纖維, and the symptoms include severe forgetfulness and memory impairment, resulting in embarrassment or perception to mitigate such disorders. In the world, woojeung (迂 遠 症) or ambition (warning) that precedes the military sound appears, the judgment or reasoning power is lowered, the productive thinking is lost, the calculation power is deteriorated, and the judgment on the situation becomes impossible. Symptoms of back.
감정의 불안전성이 뚜렷하며, 자극성이 나타나 흥분하기 쉽고, 때로는 억울해 하거나 또는 회의를 잘 느끼며, 피해망상을 일으키기도 한다. 완고하며 화를 잘내고 자기중심적이며 아집적(我執的)인 성격변화가 뚜렷해진다.Emotional instability is evident, irritating and prone to excitement, sometimes repulsive, skeptical, and delusional. Stubborn, angry, self-centered, and subtle personality changes become apparent.
행동면에서도 활발한 면에서는 절제가 없는 이상적인 적응을 하지 못하여 생기는 행동이 현저해지며, 활발성이 없는 면에서는 게으름이나 불결이 나타나고, 병형(病型)으로는 단일치매(軍一痴), 섬망착란형(妄錯亂型), 망상형(妄想型) 등이 있으며, 확실한 치료법은 없다.In terms of behavior, the behavior caused by inadequate adaptation without temperance is remarkable, laziness and impurity appear in the absence of inactivity, and as a disease type, single dementia and delirium There are forms, reticular forms, etc. There is no definite treatment.
노인성 치매는 인체의 노쇠과정에서 신기의 쇠퇴와 함께 신체 외부의 각종 자극적인 요인에 의해 발생된다고 하며, 그 원인으로는 상처, 독거, 경제적 압박, 사회적 격리나 고독, 정신적 충격, 뇌동맥 경화, 뇌출혈, 뇌빈혈 등을 들 수 있다.Geriatric dementia is caused by deterioration of the body and various stimulating factors outside the body during the deterioration of the human body.The causes are wounds, living alone, economic pressure, social isolation or loneliness, mental shock, cerebral arteriosclerosis, cerebral hemorrhage, Cerebral anemia and the like.
특히, 한의학적 원인으로는 기허, 혈허, 심화항성(心火亢盛), 혈어기체(血瘀氣滯), 간신의 음허, 심비의 양허(兩虛), 간울양항(肝鬱陽亢), 정수(精髓)의 결핍, 습담(濕淡)의 심규(心竅) 등 많은 원인이 있다.In particular, the causes of oriental medicine are Guhe, Heo Hui, Deepening Stars (心火 亢 盛), Blood Fish (간), Ganxin Hui, Shenbi Yang (양), Ganul Yanghang (肝鬱 陽 亢), Water purification (精髓) deficiency, schizophrenia (심) Shimgyu (心 竅) has many causes.
사용되는 한약은 주로 쇠약한 몸과 정신을 도우는 양심익기약(養心益氣藥)류와 정신과 마음을 편안하게 하는 영신정지(寧神定志)약류 등을 사용하고, 이 약물치료와 함께 침구치료 및 추나요법 등도 병행하고 있으며, 침치료 방법도 이용한다.Chinese medicines are mainly used for the conscience body medicine to help the debilitated body and spirit, and the spirit medicine stop medicine to relax the mind and mind. Acupuncture treatments and additional treatments are also combined, and acupuncture treatments are also used.
뿐만 아니라, 간신음분(肝賢陰分)을 보하는 방향으로 하여 뇌의 영양과 기능을 보해 주는 육미지황탕이나 팔미지황탕 등을 장복하게 하며, 양기를 머리로 보내고 기운을 충실하게 만드는 방향으로 보중익기탕, 경옥고, 십전대보탕, 쌍화탕, 좌귀음, 우귀음 등의 약에 가감하여 처방을 하기도 한다.In addition, he puts on the Yumiji Yellow Tang and Palmiji Yellow Tang, which show the nutrition and function of the brain in the direction to protect the liver, and to give energy to the head and to enhance the energy. Ikgi-tang, Kyungokgo, Sukjeondaebotang, Ssanghwa-tang, left ear, right ear, etc. may be added to or prescribed the medicine.
한편, 심층수(선도액)란 해양학적 관점에서 볼 때 해저 1000m 이하의 깊이에 있는 바닷물을 의미하며, 광합성에 의한 유기물 생성이 일어나지 않고 분해가 탁월하며 겨울철 해수 수직 혼합(海水垂直混合)작용이 도달하는 심도(深度)의 이하에 있는 해수로서 바닷물의 깊이에 따라 성분이 다르고, 화학적, 생물학적 위험 및 환경오염 등에 영향을 거의 받지 않아 대단히 깨끗한 물이며, 전형적으로 높은 물리적 안전성을 가진 대단위의 물분자들이 집합체로 뭉쳐져서 낮은 온도에서 형성되어지고, 대량의 미량원소와 미네랄 등을 포함하고 있을 뿐만 아니라 무기영양소금이 포함되어 있어 물부영양화 현상이 뚜렷하여 건강음료로서 사용되어 질 뿐만 아니라 신선한 제품, 음식, 살아있는 조직(장기)의 신선도를 유지시켜주고 피부 표면의 활력을 증진시키는 피부 보호 기능까지 하는 것으로 알려지고 있다.On the other hand, deep water (leading liquid) refers to seawater at a depth of 1,000 m or less from the oceanic point of view, and does not generate organic matter by photosynthesis, is excellent in decomposition and reaches the vertical mixing of seawater in winter. It is a seawater that is below the depth of the seawater, and its composition varies according to the depth of seawater, and it is very clean water because it is hardly affected by chemical, biological hazards and environmental pollution, and large water molecules with high physical safety are typically It is aggregated into aggregates and is formed at low temperature, and contains not only a large amount of trace elements and minerals, but also inorganic nutritional salts, so that water eutrophication is not only used as a health drink, but also fresh products, food, Maintains the freshness of living tissue (organs) and promotes the vitality of the skin surface It is known that until the unit protection.
특히, 기능성 생수 제조나 화장품 생산에 활용되고, 해조류 배양 및 어류사육, 어장 비옥화, 종묘생산 등 수산분야와 화장품, 생수, 비누, 소금, 조미료 등 식품 개발, 의약품 개발, 농업 및 공업분야 등에 활용이 기대되고, 일본에서는 심층수(선도액)를 사용해 만든 부두, 된장, 청주, 절인 반찬, 스포츠 드링크 등이 출시되어 호평을 받고 있다.In particular, it is used for the production of functional bottled water and cosmetics, and it is used for fisheries such as seaweed culture and fish breeding, fertilization of fisheries, seedling production, food development such as cosmetics, bottled water, soap, salt, seasoning, medicine development, agriculture and industrial fields. In Japan, pier, miso, sake, pickled side dishes, and sports drinks made with deep water are popular and popular.
그러나, 아직까지 심층수(선도액)에 대한 많은 연구가 이루어지지 않아 다양한 용도로의 적용이 미미한 상황이고, 치매의 치료와 예방을 위한 용도로 적용된 사례는 전무한 실정이다.However, many studies on deep water (leading fluid) have not been carried out yet, so the application to various uses is insignificant, and there have been no cases of application for the treatment and prevention of dementia.
또한, 한약재들은 다양한 임상 경험을 토대로 하여 다양한 증상에 적용되는 많은 약재들이 있으나, 치매에 전문적으로 적용되는 예는 거의 없었고, 단순한 증상에 따라 임상적인 배합이 적용되고 있는 실정이다.In addition, there are many medicines that are applied to various symptoms based on various clinical experiences, but there are few examples that are professionally applied to dementia, and clinical formulations are applied according to simple symptoms.
그리고, 원자번호 32, 원자량 72.59의 게르마늄은 금속아닌 아금속 원소로 흙속이나 식물에도 함유되어 있으며, 한국 인삼에는 4,189ppm, 마늘 754ppm, 구기자 124ppm, 컴프리 152ppm, 산두근 257ppm이 함유되어 있는데, 게르마늄이 현존하는 항암제와는 다른 차원의 제암효과가 있는 것은 모두가 게르마늄이 지닌 생체내에서 산소를 놀랍도록 풍부하게 해주는 작용과 인터페론 유도체로서의 역할 때문임이 연구 결과 밝혀졌다.Germanium with an atomic number of 32 and atomic weight of 72.59 is a nonmetallic element and is also contained in soil and plants.Korean ginseng contains 4,189ppm, garlic 754ppm, wolfberry 124ppm, comfrey 152ppm, and 257ppm of wild boil. The results show that all of the anticancer effects that differ from existing anticancer drugs are due to the germanium's incredible enrichment of oxygen in vivo and its role as an interferon derivative.
생체란 보는 관점에 따라서는 전기의 극초미립자의 응집체라고 할 수 있다. 각 기관, 각 부분은 각각 고유의 응집체로서 기능하고 있다. 때문에 각 부분은 정해진 전위가 있고, 그 전위가 뒤틀린 것이 질병이며, 뇌파측정기나 심전도는 이 전위의 변화를 측정함으로써 장애를 찾아내는 기기이고, 이 뒤틀린 전위를 바로 잡는데 게르마늄이 놀라운 역할을 한다.The living body can be said to be an aggregate of ultrafine particles of electricity depending on the viewpoint. Each engine and each part function as a unique aggregate. Therefore, each part has a defined potential, and the distorted potential is a disease. An electroencephalogram or an electrocardiogram is a device for detecting a disorder by measuring a change in the potential, and germanium plays an amazing role in correcting the distorted potential.
예를 들어, 암세포의 전위를 살펴보면 다른 정상세포의 전위와는 판이하게 다르다. 암세포는 맹렬한 속도로 세포증식을 계속하기 때문에 그 전위가 높고 심하게 격변하고 있지만 게르마늄은 그 높은 전위를 지닌 암세포로부터 전자를 빼앗아전위를 낮추는 작용을 하므로서 진행중인 이상세포(암세포)의 활동을 중지시키는 역할을 하며, 암의 전이를 막는 이유이기도 하다.For example, looking at the potential of cancer cells is quite different from the potential of other normal cells. Since cancer cells continue to proliferate at a violent rate, the potential is high and severely deformed, but germanium takes electrons away from the cancer cells with the high potential and lowers the potential, thereby stopping the activity of abnormal cells (cancer cells) in progress. It is also the reason for preventing cancer metastasis.
게르마늄은 물론 혈액을 비롯한 각 세포는 반도체의 성질을 지니고 있는데 반도체끼리는 그 전자물성으로 보아 공존할 수 없기 때문에 여분의 게르마늄이 체내에 축적될 우려가 전혀 없으며 축적될 수 없다는것은 아무리 많이, 장기간 투여해도 여분의 게르마늄은 배설되기 때문에 부작용이 없다는 뜻이기도 하다.Germanium, as well as blood, each cell has the characteristics of a semiconductor, semiconductors can not coexist in terms of their electronic properties, so there is no risk of excess germanium accumulate in the body, no matter how much, even long-term administration Extra germanium is also excreted, which means there are no side effects.
최근 유기(有機) 게르마늄에 대한 관심이 높아지면서 그의 뛰어난 효능이 인정됨에 따라 기능성 치유물질로 높은 평가받고 있으며, 폐암, 방광암, 유암, 노이로제, 천식, 심부전, 축농증, 신경통, 백혈병, 뇌연화증, 자궁근종, 간경병 등 모든 병에서 게르마늄은 놀라운 효과를 나타내고 있다.Recently, as interest in organic germanium has increased, its excellent efficacy is recognized, and it is highly regarded as a functional healing substance, and it is highly regarded as a lung cancer, bladder cancer, breast cancer, neurosis, asthma, heart failure, sinusitis, neuralgia, leukemia, cerebral malaise, uterine fibroids. In all diseases, including cirrhosis and cirrhosis, germanium has an amazing effect.
특히, 우리들 인간은 살아가기 위해서 음식물을 먹는데, 흡수되지 않은 것은 대변으로 배설되지만 소화기관에서 흡수된 것은 여러가지 과정을 거쳐 산소에 의해 체내에서 연소되며, 최후로 탄산가스와 물이 되어 체외로 배설, 즉, 가스상태의 탄소는 산소와 결합되어 탄산가스로서 호기에 의해 몸 밖으로 나오며, 또 하나의 가스인 수소이온은 산소와 결합되어 물로 땀이나 소변으로 배설되지만 수소는 양이온으로 생체내에서는 전혀 쓸모가 없으며 수소량이 많을수록 중화에 필요한 산소의 양도 많이 요구되므로 이런 경우 게르마늄을 투여하면 산소 대신 수소와 결합하여 배설되기 때문에 몸안의 산소가 낭비됨이 없이 기능회복, 세포수복등 본래의 역할, 건강에 절대적으로 필요한 역할을 하게 되는 것이다.In particular, we humans eat food in order to live, but what is not absorbed is excreted in feces, but what is absorbed in the digestive system is burned in the body by oxygen through various processes, and finally, it is excreted in the body as carbon dioxide and water, That is, gaseous carbon is combined with oxygen and comes out of the body by exhalation as carbon dioxide gas. Another gas, hydrogen ions, is combined with oxygen and excreted in sweat or urine with water, but hydrogen is a cation and is completely useless in vivo. In addition, the higher the amount of hydrogen, the greater the amount of oxygen required for neutralization. In this case, germanium is administered in combination with hydrogen instead of oxygen. Therefore, oxygen is not wasted in the body. It will play the necessary role.
그러나, 이와 같은 게르마늄의 효능이 알려졌음에도 불구하고 아직까지 심층수와 병용하므로서 치매에 우수한 치료 및 예방에 상승적인 효과가 발현된다는 사실은 보고된 바 없다.However, although the efficacy of such germanium is known, it has not been reported that synergistic effects on the treatment and prevention of dementia are exhibited in combination with deep water.
따라서, 본 발명의 목적은 정제된 심층수(선도액), 유기 게르마늄(Ge-132) 및 한약재를 주재료로 하여 건강보조식품으로서의 효능 뿐만 아니라 치매에 우수한 치료 및 예방 효과를 나타내는 건강보조식품을 제공하는 데 있다.Accordingly, an object of the present invention is to provide a dietary supplement showing excellent therapeutic and preventive effects on dementia as well as efficacy as a dietary supplement based on purified deep water (freshness solution), organic germanium (Ge-132) and herbal medicine as a main ingredient. There is.
본 발명의 다른 목적은 상기 목적의 건강보조식품을 용이하게 제조하는 방법을 제공하는 데 있다.Another object of the present invention to provide a method for easily preparing a health supplement of the above object.
상술한 목적들 뿐만 아니라 용이하게 표출될수 있는 또 다른 목적들을 달성하기 위하여 본 발명에서는 해저 600m의 심층수와 1400m의 심층수를 정제하여 적정한 비율로 혼합한 정제된 심층수(선도액) 60 ∼ 74.5중량%, 하수오, 진피, 탱자열매, 생강, 울금, 복령, 죽엽, 천마, 누에분말, 석창포 및 감초로 구성되는 한약재 추출물 25 ∼ 39.5중량% 및 유기 게르마늄(Ge-132) 0.5 ∼ 15중량%로 구성되어지되 정제된 심층수(선도액), 한약재 추출물 및 유기 게르마늄(Ge-132)을 혼합하여 본 발명의 건강보조식품을 얻고, 이를 복용하게 하므로서 치매에 우수한 치료 및 예방 효과를 얻을 수 있었다.In order to achieve not only the above-mentioned objects but also other objects that can be easily expressed, in the present invention, 60 to 74.5% by weight of purified deep water (leading liquid), which is mixed at an appropriate ratio by purifying deep water of 600 m and deep water of 1400 m, It is composed of 25 ~ 39.5% by weight of herbal extracts consisting of sewage, dermis, tangerine, ginger, turmeric, fuyeong, bamboo leaf, cheonma, silkworm powder, Seokchangpo and licorice, and 0.5-15% by weight of organic germanium (Ge-132). Purified deep water (preparative solution), herbal medicine extract and organic germanium (Ge-132) was mixed to obtain the health supplement of the present invention, and by taking it to obtain an excellent treatment and preventive effect on dementia.
본 발명을 좀 더 상세히 설명하면 다음과 같다.The present invention is described in more detail as follows.
본 발명에 따른 치매에 우수한 치료 및 예방 효과를 갖는 건강보조식품은 해저 600m의 심층수와 1400m의 심층수를 정제하여 적정한 비율로 혼합한 정제된 심층수(선도액) 60 ∼ 74.5중량%, 하수오, 진피, 탱자열매, 생강, 울금, 복령, 죽엽, 천마, 누에분말, 석창포 및 감초로 구성되는 한약재 추출물 25 ∼ 39.5중량% 및 유기 게르마늄(Ge-132) 0.5 ∼ 15중량%로 구성되는 것으로 특징지워진다.Health supplement food having excellent treatment and preventive effect on dementia according to the present invention 60 to 74.5% by weight of purified deep water (leading solution), purified by mixing the depth of the seabed 600 m deep water and 1400 m deep water in the appropriate ratio, sewage, dermis, It is characterized by consisting of 25 ~ 39.5% by weight of Chinese herbal extracts consisting of tangerberry, ginger, turmeric, Fuling, bamboo leaf, cheonma, silkworm powder, Seokchangpo and licorice and 0.5 to 15% by weight of organic germanium (Ge-132).
또한, 본 발명에 따른 치매의 치료와 예방에 효과적인 건강보조식품의 제조방법은 해저 600m의 심층수와 1400m의 심층수를 정제하여 적정한 비율로 혼합한 다음에 별도로 하수오, 진피, 탱자열매, 생강, 울금, 복령, 죽엽, 천마, 누에분말, 석창포 및 감초로 구성되는 한약재로부터 추출물을 얻은 후에 이를 정제하고, 정제된 심층수(선도액), 한약재 추출물 및 유기 게르마늄(Ge-132)을 균질하게 혼합하는 것으로 특징지워진다.In addition, the manufacturing method of the health supplement food effective for the treatment and prevention of dementia according to the present invention is purified by mixing the depth of the seabed 600m deep water and 1400m deep water in an appropriate ratio and then sewage, dermis, tangerine, ginger, turmeric, After extracting the extract from the herbal medicine consisting of Bokryeong, bamboo leaf, cheonma, silkworm powder, Seokchangpo and licorice, and purified it, characterized in that homogeneous mixing of the purified deep water (freshening liquid), herbal extract and organic germanium (Ge-132) It is erased.
본 발명에서 사용된 해저 600m의 심층수와 1400m의 심층수의 성분은 다음의 표 1과 같다.The components of the deep sea water of 600m and the deep seawater of 1400m used in the present invention are shown in Table 1 below.
[표 1]TABLE 1
상기 표 1로부터 알 수 있는 바와 같이 심층수(선도액)에는 다양한 무기물 및 미량원소가 다량으로 함유되어 있고, 본 발명에서는 해저 600m의 심층수와 1400m의 심층수를 1 : 3 ∼ 3 : 1의 비율로 혼합하여 사용하였다.As can be seen from Table 1 above, the deep water (leading liquid) contains various inorganic substances and trace elements in a large amount, and in the present invention, the deep water of 600 m and the deep water of 1400 m are mixed at a ratio of 1: 3 to 3: 1. Was used.
해저 600m의 심층수와 1400m의 심층수를 혼합하여 사용하는 것이 바람직하지만 해저 600m 이상의 심층수면 모두 사용이 가능하며, 심층수(선도액)는 대량의 미량원소와 미네랄 등을 포함하고 있을 뿐만 아니라 무기영양소금이 포함되어 있어 물부영양화 현상이 뚜렷하여 살아있는 조직(장기)의 신선도를 유지시켜주는 기능을 하기 때문에 효과적일 뿐만 아니라 인체에 균형을 유지케 하여 치매의 원인을 치유케하며, 심층수(선도액)를 취하여 -4 ∼ 0℃의 온도를 유지하면서 1 ∼ 2일간 정치하여 침전물을 제거한 후에 여과하는 방법으로 정제한 것을 사용한다.It is preferable to use a depth of 600m deep water and 1400m deep water, but it is possible to use both deep water of 600m or more deep sea water, and the depth water (leading liquid) contains a large amount of trace elements and minerals as well as inorganic nutrient salts. Because it contains water nutrient nutrients, it maintains the freshness of living tissues (organs), and it is effective and maintains the balance of the human body to heal the cause of dementia. The thing refine | purified by the method of filtering after standing still for 1-2 days, removing a deposit, maintaining the temperature of -4-0 degreeC is used.
심층수(선도액)의 사용량은 60 ∼ 74.5중량%가 바람직하며, 사용량이 60중량% 미만일 경우에는 치매에 우수한 치료 및 예방 효과가 만족스럽지 못하고, 74.5중량%를 초과할 경우에는 건강보조식품으로서의 효능이 저하되는 단점이 있다.The amount of deep water (leading liquid) is preferably 60 to 74.5% by weight, and when the amount is less than 60% by weight, excellent treatment and prevention effects on dementia are not satisfactory, and when it exceeds 74.5% by weight, it is effective as a dietary supplement. This has the disadvantage of deteriorating.
유기 게르마늄(Ge-132)은 순도와 안전도가 매우 중요하며 체내에서의 소화 흡수 또한 매우 중요하기 때문에 분말 형상인 것을 심층수(선도액)에 용해하여 사용하며, 분말의 상태가 순백색이고, 입자나 알갱이 같은 것이 없이 밀가루처럼 고우며, 분말의 상태가 덩어리처럼 뭉친 것이 없고, 불순물이 섞여 있지 않은 것을 사용하여야 하며, 60 ∼ 80℃의 물(증류수면 더 정확함) 50cc에 유기게르마늄 분말 20mg을 넣고 교반시 물에 완전히 용해되고, 용해후 오랜 시간이 지나도 침전물(불순물)이 생기지 않아야 하며, 물에 완전히 녹은 후에는 물이 크리스탈처럼 보통의 물보다 더 맑고 투명하게 되는 것을 선택하여 사용한다.Organic germanium (Ge-132) is very important for its purity and safety, and its digestion and absorption in the body is also very important. So, it is used by dissolving it in deep water (leading liquid), and the state of powder is pure white. No matter the same, flour is fine, powder is not agglomerated like agglomerate, and it should be used without any impurities.Add 20mg of organic germanium powder to 50cc of water at 60 ~ 80 ℃ (more accurate distillation surface) and stir. It is completely soluble in water, and no sediment (impurity) should be formed after a long time after dissolution. After being completely dissolved in water, the water is selected to be clearer and more transparent than ordinary water like crystal.
유기게르마늄이 함유하고 있는 산소는 세포안에서 발생기 산소로 방출되는데, 보통 산소는 통상적인 상태에서는 분자 O2의 형태로 존재하지만 다른 물질과 화합할 때는 산소원자 O의 형태가 되며, 유기게르마늄은 발생기 산소를 빈사직전의 세포에 방출시켜 세포를 부활시키므로서 대사활동이라는 세포내 화학반응을 활성화시키게 되고, 세포는 본래의 기능을 되찾아 싱싱하게 작용하게 되며, 결과적으로 온몸의 컨디션이 호전되어 치매의 병인이 제거되는 것이다.The oxygen contained in organo germanium is released into the generator oxygen in the cell. Normally, oxygen exists in the form of molecule O 2 in a normal state, but when combined with other substances, it becomes in the form of oxygen atom O, and organo germanium is generator oxygen. It releases to the cells just before death and activates the intracellular chemical reaction called metabolic activity, and the cells regain their original function and work freshly. As a result, the condition of the whole body improves and the etiology of dementia is improved. To be removed.
산의 바탕은 산소가 아니고 수소, 보다 정확하게 말하면 수소이온이고, 수소이온은 체내에서 쓸모가 전혀 없는 가스에 불과하지만 그것이 정도 이상으로 축적되면 체질이 산성화되었다고 하며, 컨디션을 무너뜨리는 계기가 되는 데, 이 불필요한 가스를 청소하는데 산소가 필요하며, 산소는 필요없는 수소이온과 결합하여 중성인 물이 되어 몸밖으로 배설되는데 유기게르마늄은 그것을 위한 산소를 공급하는 작용을 하며, 수은이나 카드뮴같은 유해한 중금속을 동반해서 체외로 배설시켜 주는 역할을 한다.The base of the acid is not oxygen, but hydrogen, more precisely hydrogen ions, and hydrogen ions are nothing but useful gases in the body, but when they accumulate more than that, the constitution is said to be acidified. Oxygen is needed to clean up this unnecessary gas, and oxygen combines with hydrogen ions, which are not needed, to form neutral water and be excreted out of the body. Organic germanium acts to supply oxygen for it, accompanied by harmful heavy metals such as mercury and cadmium. It acts to excrete outside the body.
본 발명에서는 버섯, 고려인삼, 밤, 구기자 열매 등과 같이 게르마늄이 고단위로 함유되어 있는 식용 가능한 식물로부터 분리한 것으로, 마늘, 컴프리, 알로에, 표고버섯같은 버섯류도 유기 게르마늄(Ge-132)원으로 사용될 수 있으며, "카르복시 에틸 게르마늄 32산화물"(분자식 : (GeCH2CH2COOH)2O3)이 특히 효과적이다.In the present invention, it is isolated from edible plants containing germanium in a high unit such as mushrooms, Korean ginseng, chestnuts, goji berries, etc., mushrooms such as garlic, comfrey, aloe, shiitake mushrooms can also be used as a source of organic germanium (Ge-132) And "carboxy ethyl germanium 32 oxide" (molecular formula: (GeCH 2 CH 2 COOH) 2 O 3 ) is particularly effective.
유기 게르마늄(Ge-132)의 사용량은 0.5 ∼ 15중량%가 바람직하며, 사용량이 0.5중량% 미만일 경우에는 유기 게르마늄(Ge-132)의 효과 발현이 미약한 단점이 있고, 사용량이 15중량%를 초과할 경우에는 첨가 상승효과가 미약하여 경제적이지 못한 단점이 있다.The amount of organic germanium (Ge-132) is preferably 0.5 to 15% by weight, and when the amount is less than 0.5% by weight, the effect of organic germanium (Ge-132) is weakly expressed. If exceeded, there is a disadvantage in that the synergistic effect of addition is weak and not economical.
한편, 한약재는 치매에 우수한 치료 및 예방에 효능이 있는 것으로 알려져 있는 하수오, 진피, 탱자열매, 생강, 울금, 복령, 죽엽, 천마, 누에분말, 석창포 및 감초를 사용하며, 한약재를 열수 추출하여 정치한 다음 여과한 것이 효과적이고, 한약재의 사용량은 25 ∼ 39.5중량%가 바람직하며, 사용량이 25중량% 미만일경우에는 건강 보조 식품으로서의 효능 발현이 미약한 단점이 있고, 39.5중량%를 초과할 경우에는 심층수(선도액)와 유기 게르마늄(Ge-132)의 사용량이 상대적으로 감소되어 치매에 우수한 치료 및 예방 효과가 미약한 단점이 있다.Meanwhile, Chinese herbal medicine uses sewage, dermis, tanza fruit, ginger, turmeric, bokyeong, bamboo leaf, cheonma, silkworm powder, Seokchangpo and licorice, which are known to be effective in the treatment and prevention of dementia. After filtration is effective, the use of the herbal medicine is preferably 25 to 39.5% by weight, when the amount is less than 25% by weight, there is a disadvantage in the expression of efficacy as a dietary supplement, when it exceeds 39.5% by weight As the amount of deep water (leading liquid) and organic germanium (Ge-132) is relatively reduced, it has a weak treatment and preventive effect on dementia.
특히, 하수오는 신장과 간장의 정혈을 보익하여 노화를 방지하는 효능이 있는 것으로 알려져 있으며, 진피와 탱자열매는 소화기능을 향상시켜 몸안의 노폐물을 제거하는 효과가 있고, 생강은 여러 가지 약물의 독성을 제거하는 효과가 있으며, 울금은 탁한 기혈을 맑게 하고 뇌의 혈류량을 증대시켜 정신을 맑게하는 효과가 있고, 복령과 죽엽은 담영이 울결된 것을 다스려 치매 증상을 억제하며 정신을 맑게하고 불면증을 치료하는 효과가 있는 것으로 알려져 있다.In particular, sewage is known to be effective in preventing aging by supplementing the renal blood of the kidneys and liver, and dermis and tanberry fruit improve digestion and remove waste products from the body. Ginger is toxic of various drugs. It is effective in removing turbidity, turmeric clears turbid blood and increases brain blood flow, and clears the mind. It is known to have a therapeutic effect.
뿐만 아니라, 천마와 누에분말은 건망증, 의식장애, 신경쇠약 및 경련성 질환을 치료하는 효과가 있고, 석창포는 기를 맑게 하여 막힌 것을 뚫어주는 기능이 있어 정신혼미, 기억력 감퇴를 치료하는 효과가 있으며, 감초는 기를 보익하는 동시에 해독작용을 하며 구성 한약재들을 조화롭게 하는 효과가 있다.In addition, Chunma and silkworm powder have the effect of treating forgetfulness, consciousness disorder, nervous breakdown and convulsive disease, and Seokchangpo has the function to clear the block and penetrate the blockage, and to treat mental confusion and memory loss, licorice. At the same time, it replenishes qi and detoxifies and harmonizes the medicinal herbs.
본 발명의 건강보조식품은 작용기전이 정확히 밝혀지지 않았지만 대뇌혈류를 개선함으로써 뇌에서 저하된 신경세포의 여러 가지 기능을 개선시키고, 콜린성 신경전달물질의 합성을 촉진시켜 기억 및 인지 기능을 향상시키므로써 치매의 치료와 예방에 우수한 효과를 나타내는 것으로 추측된다.The dietary supplement of the present invention, although the mechanism of action is not exactly known, by improving the cerebral blood flow improves the various functions of neurons that are degraded in the brain, by promoting the synthesis of cholinergic neurotransmitters to improve memory and cognitive function It is believed to have an excellent effect on the treatment and prevention of dementia.
다음의 실시예는 본 발명을 좀 더 상세히 설명하는 것이지만, 본 발명의 범주를 한정하는 것은 아니다.The following examples illustrate the invention in more detail, but do not limit the scope of the invention.
실시예 1Example 1
해저 600m의 심층수와 1400m의 심층수를 취하여 -4 ∼ 0℃의 온도를 유지하면서 1일간 정치하여 침전물을 제거한 후에 여과하는 방법으로 정제한 다음, 해저 600m의 심층수와 1400m의 심층수를 1 : 1의 비율로 혼합한다.Take 600m deep water and 1400m deep water and leave it for 1 day while maintaining the temperature of -4 ~ 0 ℃, remove the precipitate, and then purify by filtering. Then, 600m deep water and 1400m deep water is 1: 1 ratio. Mix with.
별도로 하수오, 진피, 탱자열매, 생강, 울금, 복령, 죽엽, 천마, 누에분말, 석창포 및 감초 각각 15g을 열수에 투입하고 6시간 동안 열수 추출한 다음, 실온으로 냉각하고 1일간 정치한 후, 침전물을 제거하여 한약재 추출물을 준비한다.Separately, 15 g of sewage, dermis, tangerberry, ginger, turmeric, bokyeong, bamboo leaf, cheonma, silkworm powder, Seokchangpo and licorice were added to hot water, extracted with hot water for 6 hours, cooled to room temperature and allowed to stand for 1 day. Prepare herbal extracts by removing them.
그 다음에 심층수(선도액) 혼합물 68중량%, 한약재 추출물 30중량%와 식물성 카르복시 에틸 게르마늄 32산화물 2중량%를 혼합하고 교반하여 식물성 카르복시 에틸 게르마늄 32산화물이 완전히 용해되고, 각각의 성분들이 균질하게 혼합되도록 하여 본 발명의 치매 치료 및 예방에 효과적인 건강보조식품을 제조하였다.Then, 68% by weight of the deep water mixture (preliminary solution), 30% by weight of the herbal extract and 2% by weight of the carboxyethyl germanium 32 oxide are mixed and stirred to completely dissolve the vegetable carboxyethyl germanium 32 oxide, and the components are homogeneously It was mixed to prepare a dietary supplement effective for the treatment and prevention of dementia of the present invention.
실험예 1Experimental Example 1
본 발명에 따른 건강보조식품의 인체에 대한 무독성을 입증하기 위하여 마우스를 대상으로 급성독성시험을 실시하였다.In order to prove the non-toxicity of the health food according to the present invention to the human body, an acute toxicity test was conducted in mice.
[급성독성시험][Acute Toxicity Test]
(1) 재료 및 방법(1) materials and methods
가) 실험동물A) Experimental animal
1) 종(계통) : ICR계 마우스(ICR mouse)1) Species: ICR mouse
2) 성별 및 입수시 주령 : 수컷 4주령2) Gender and age at acquisition: Male 4 weeks
3) 선택이유 : 본 실험에 사용된 ICR계 마우스는 전세계적으로 독성시험에 널리 사용되어 왔기 때문에 생리, 해부 및 독성학적 기초자료가 풍부하여 그 결과를 비교하기가 유리하고 또한 실험동물의 구입 및 사용이 편리하여 선택하였다.3) Reason for selection: Since the ICR mice used in this experiment have been widely used in toxicology tests all over the world, it is rich in basic physiological, anatomical and toxicological data, so it is advantageous to compare the results. Selected for ease of use.
4) 공급원 : 대륙시험동물4) Source: Continental Test Animal
5) 검역 및 순화기간 : 실험실에 순화시키는 기간을 약 1주일 두었으며, 그 기간중 일반증상을 관찰하여 건강한 동물만을시험에 사용하였다.5) Quarantine and Purification Period: The laboratory was allowed to purify for about 1 week. During the period, general symptoms were observed and healthy animals were used for the test.
6) 정맥주사시 체중범위 및 주령 : 20±3g, 5주령6) Weight range and age at intravenous injection: 20 ± 3g, 5 weeks
7) 사용동물수 : 100마리(예비시험 포함)7) Number of animals: 100 (including preliminary test)
8) 군 분리 및 동물시별 : 시험에 사용된 건강한 동물의 체중을 측정하여 각 군의 평균체중이 거의 일치하도록 군 분리를하였고, 개체식별은 피모색소(피크린산) 마킹법과 사육상자별 TAG 표시법을 이용하였다.8) Group Separation and Animal Time: The weights of healthy animals used for the test were divided into groups so that the average weight of each group was almost identical. The individual identification was performed by the method of marking pigmented pigment (picrinic acid) and TAG by breeding box. Was used.
나) 동물실B) animal room
1) 온, 습도범위 : 온도 22±2℃, 상대습도 53±2%1) Temperature and humidity range: temperature 22 ± 2 ℃, relative humidity 53 ± 2%
2) 명암 사이클 : 형광등조명(09:00 점등~18:00 소등)2) Contrast cycle: Fluorescent lighting (09:00 to 18:00 off)
3) 조도 : 150~300Lux3) Roughness: 150 ~ 300Lux
4) 사육상자의 종류 : 순화, 검역, 투여 및 관찰기간 중 마우스용 플리카보네이트(polycarbonate)케이지 (대종기계제작)4) Types of breeding box: Polycarbonate cage for mouse during purifying, quarantine, administration and observation period (manufactured by Daejong Machinery)
5) 사육상자당 동물수 : 순화, 검역기간 -5마리5) Number of animals per breeding box: Purified, quarantine period-5
투여기간-5마리Dosing period-5
다) 사료C) feed
1) 종류 : 실험동물용 고형사료1) Type: Solid feed for laboratory animals
2) 공급원 : 삼양유지사료주식회사2) Source: Samyang Oil Feed Co., Ltd.
라) 음수D) negative
1) 종류 : 여과된 수도수1) Type: filtered tap water
마) 시험물질E) test substance
1) 시료 : 상기 실시예 1에서 제조된 조성물(1000배 희석액)1) Sample: The composition prepared in Example 1 (1000-fold dilution)
공시험액(음성대조군)Blank test amount (negative control)
바) 투여방법F) Method of administration
1) 투여경로 : 경구투여(Oral)1) Route of administration: Oral administration (Oral)
2) 투여회수 및 투여기간 : 1회투여2) Number of administration and period of administration: 1 administration
3) 투여부위 및 투여법 : 마우스에 경구투여하였다.3) Administration site and administration method: The mice were orally administered.
4) 투여시각 : 10:00~12:004) Administration time: 10: 00 ~ 12: 00
5) 투여량 : 투여직전에 체중을 기준으로 하여 50ml/kg를 투여하였다.5) Dosage: 50ml / kg was administered immediately based on body weight.
(2) 시험방법(2) Test method
가) 국립보건원 독성시험에 따라 실시하였다.A) It was conducted in accordance with the National Institutes of Health toxicity test.
나) 임상증상관찰 : 전 동물에 대하여 매일 실시하였다.B) Clinical symptoms observation: All animals were conducted daily.
투여 후 6시간은 매시간 관찰하여 그후 5일간 1일 1회 운동성, 외관 및 자율신경증상을 주의 깊게 관찰하였다.Six hours after the administration was observed every hour, and carefully observed the mobility, appearance and autonomic symptoms once daily for 5 days thereafter.
(3) 시험결과(3) Test result
[표 2]TABLE 2
급성독성시험결과Acute Toxicity Test Results
이상의 결과에서 알 수 있는 바와 같이, 본 발명 실시예의 건강보조식품과 음성대조군의 경구투여 후 2주간의 관찰 결과, 체중과 운동성이 정상적인 것으로 관찰되었다.As can be seen from the above results, two weeks after oral administration of the health supplement food and the negative control group of the present invention, body weight and motility were observed to be normal.
실험예 2Experimental Example 2
위스터계 랫트(숫컷) 11주령을 사용하여 다음의 조건에서 시험을 행하였다. 시험기간을 통한 사육 방법은 환경은 동일한 것으로 하고 급식만 변화시켰다. 공통의 먹이로서는 랫트의 성장에 지장이 없도록 조정한 20% 카제인식을 적용하여 이것을 준비하였다. 급식방법은 스페에시드 휘딩법을 사용하여 매일 정시의 4시간 마다 15g을 섭취하도록 하였다. 또한, 물은 자유롭게 섭취하도록 하였다.The test was conducted under the following conditions using 11-week-old Wister rats (males). The breeding method through the trial period changed the feed with the same environment. As a common food, this was prepared by applying a 20% casein expression adjusted so that rat growth was not hindered. The feeding method was to consume 15 g every four hours on a daily basis using the speside fidding method. In addition, water was allowed to be ingested freely.
기억보지장애의 발증을 위해서는 이보텐산(Sigma회사제 제품명 IBOTENIC ACID)를 생리식염수 완충액에 용해하여 30nmol/㎖의 이보텐산 용액을 사용하였다.For the onset of memory impairment, ivothenic acid (IBOTENIC ACID, manufactured by Sigma) was dissolved in physiological saline buffer and 30 nmol / ml ivothenic acid solution was used.
랫트를 마취한 후 뇌를 고정시키고, 마이크로 시린저로 랫트뇌의 중혁핵(A53, LO, O, OH, %, Konig Klipped의 뇌보도에 따른다)에 삽입하고, 상기 이보텐산용액 0.6ul를 5분간에 걸쳐 주입하였다. 역류방지를 위하여 5분간 정치한 후 마이크로시린저를 빼내어 랫트가 기억보지장애를 발증하도록 하였다.After anesthetizing the rat, the brain is fixed and inserted into the mid-brain nucleus (A53, LO, O, OH,%, according to the Konig Klipped brain coverage) of the rat brain with a micro syringe. Inject over minutes. In order to prevent reflux, the rat was allowed to stand for 5 minutes and then the microsyringe was removed to allow the rat to develop memory impairment.
학습시험으로서는 수미과제를 사용하였으며, 수미과제장치로서는 직경120cm,높이 40cm의 구조에 깊이 25cm까지 21도의 물을 넣고 수면아래 1cm의 위치에 표면이 10cm×10cm인 피난장소를 설치하였다.A learning task was used as a learning test, and as a task, the evacuation site was installed with a diameter of 120cm and a height of 40cm and water of 21 degrees up to 25cm in depth and a 10cm × 10cm surface at a position of 1cm below the surface of the water.
수면에는 입상의 발포스티로폴을 띄우고 랫트의 피난장소가 보이지 않도록 하였다. 수조의 둘레는 동서남북의 4포인트를 취하고 수면을 4부분으로 나누었다. 장치의 주위에는 시험자, 조명용 형광등 등 랫트에 시각적 손이 닿지 않는 사물이 있고, 여기에 시각적 손이 닿지 않는 수조내에 랫크는 잘 보이는 것을 실험기간을 통하여 일정하게 하였다.On the water surface, granulated foamed styropol was floated and the evacuation site of the rat was not visible. The circumference of the tank took 4 points of east, west, north and south and divided the water surface into 4 parts. In the vicinity of the device, there were objects such as tester and lighting fluorescent lamp, which were not visually touched to the rat, and the rat was well visible in the water tank which was not visually touched.
학습훈련은 랫트를 수조 중에 넣고 피난 장소에 도착할 때까지를 1번 시행으로 하고 적어도 10분 이상의 간격을 두고 하루에 4번의 시행을 실시하였다.In the training session, rats were placed in the tank, and the test was conducted once until they arrived at the evacuation site, and four times a day at least 10 minutes apart.
기억보지력의 확인시험은 수미과제의 조건에 따라 피난장소를 제거하여 랫트를 수조 중에 방치하여 60분간 중 피난장소에 있는 구역화된 장소에 머무르는 시간을 계측하였다.The memory test was conducted to remove the evacuation site according to the condition of the rice paddy, and to keep the rats in the tank for 60 minutes and to stay at the zoned place at the evacuation site.
기억보지장해를 일으킨 랫트와 대비하기 위해 이보텐산을 주입하지 않을 랫트를 위의 방법으로 같은 시험을 되풀이하였다. 이를 위해 각각 20마리의 랫트가 사용되었다. 이들 랫트를 17일간 공동의 먹이만으로 사육하였다. 17일간 가운에 14일과 16일째 3일 간격으로 상기 합숙훈련을 행하였다. 17일째에 기록보지력의 확인시험을 행하였다.The same test was repeated in the above method for rats that were not infused with ibothenic acid to prepare for the rats that caused memory impairment. Twenty rats each were used for this. These rats were reared for 17 days only with common food. The camping training was conducted in a gown for 17 days at intervals of 3 days on 14th and 16th days. On the 17th day, the verification test of the record holding power was conducted.
그 결과는 표 3과 같다.The results are shown in Table 3.
[표 3]TABLE 3
또한, 표준의 수치는 랫트가 피난장소구역에 머무는 시간에 대하여 각각이 랫트 20마리의 평균치이고 수치가 클수록 기억보지력이 우수하였다는 것을 나타낸다. 표 3으로부터 이보테산에 의한 기억보지장애가 일어나고 있다는 것이 확인되었다.In addition, the standard values indicate that the rats stayed in the evacuation area for 20 rats each, and the larger the value, the better the memory retention. From Table 3, it was confirmed that memory impairment caused by ivoteic acid occurred.
기억보지장애의 발증을 나타낸 랫트 40마리를 준비하고 급식은 중량에 따라 하기의 2군에서 20마리씩을 나누고 시험을 행하였다.Forty rats showing the onset of memory impairment were prepared, and feeding was conducted by dividing 20 rats from the following two groups by weight.
A군 공통의 먹이 14.2g중에 실시예 1의 건강보조식품 1g을 배합한 먹이를 주고, 비타민B12(시아노코발라민)을 증류수에 용해한 용액(3.5㎍/㎖)을 사용하여 랫트의 체중 1kg당 비타민 B1225㎍ 섭취하도록 투여하였다.Feed 1 g of the dietary supplement of Example 1 in 14.2 g of common A group food, and use a solution (3.5 μg / ml) of vitamin B 12 (cyanocobalamin) dissolved in distilled water per 1 kg of rat body weight. 25 μg of vitamin B 12 was administered.
B군 공통의 먹이만 주었다.Only B group was given common food.
[표 4]TABLE 4
표 4로부터 알 수 있는 바와 같이 본 발명의 건강보조식품은 기억보지력을 향상시켰다.As can be seen from Table 4, the health supplement of the present invention improved memory retention.
상술한 바와 같이 본 발명에서는 해저 600m의 심층수와 1400m의 심층수를 정제하여 적정한 비율로 혼합한 정제된 심층수(선도액) 60 ∼ 74.5중량%, 하수오, 진피, 탱자열매, 생강, 울금, 복령, 죽엽, 천마, 누에분말, 석창포 및 감초로 구성되는 한약재 추출물 25 ∼ 39.5중량% 및 유기 게르마늄(Ge-132) 0.5 ∼ 15중량%로 구성되어지되 정제된 심층수(선도액), 한약재 추출물 및 유기 게르마늄(Ge-132)을 혼합하여 본 발명의 건강보조식품을 얻고, 이를 복용하게 하므로서 치매에 우수한 치료 및 예방 효과를 얻을 수 있었다.As described above, in the present invention, 60 to 74.5% by weight of purified deep water (freshening solution) mixed with an appropriate ratio of purified deep water of 600m and deep water of 1400m, sewage, dermis, tangerine, ginger, turmeric, bokyeong, bamboo leaf , 25 ~ 39.5% by weight of herbal medicine extract consisting of cheonma, silkworm powder, changchangpo and licorice and 0.5 ~ 15% by weight of organic germanium (Ge-132), but purified deep water (leading liquid), herbal medicine extract and organic germanium ( Ge-132) to obtain a dietary supplement of the present invention by mixing, it was possible to obtain an excellent treatment and preventive effect on dementia.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020057658A KR20040026273A (en) | 2002-09-23 | 2002-09-23 | The health-supporting food being effective the dementia and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020057658A KR20040026273A (en) | 2002-09-23 | 2002-09-23 | The health-supporting food being effective the dementia and its preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20040026273A true KR20040026273A (en) | 2004-03-31 |
Family
ID=37328769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020020057658A KR20040026273A (en) | 2002-09-23 | 2002-09-23 | The health-supporting food being effective the dementia and its preparation method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20040026273A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1773864A1 (en) * | 2004-07-31 | 2007-04-18 | Biogrand Co., Ltd. | Silk peptide improving neuroprotective and neurofunctional effects and a method of its preparation |
KR100856567B1 (en) * | 2006-10-11 | 2008-09-04 | 김명선 | Method for make of Health Supplement Food containing Wild Ginseng root cultivated powder |
KR20160129416A (en) | 2015-04-30 | 2016-11-09 | 부산대학교 산학협력단 | Medical herb tea therapy kit for improvement of cognitive ability |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970068894A (en) * | 1996-04-24 | 1997-11-17 | 강대일 · 정영숙 | Health food composition containing minerals, herbal medicine extracts and amino acids |
KR19990085202A (en) * | 1998-05-14 | 1999-12-06 | 김기영 | Herbal composition for the prevention and treatment of dementia |
JP2002119263A (en) * | 2000-10-16 | 2002-04-23 | Kazuhiro Kotani | Sport drink utilizing ocean deep water |
KR20020066173A (en) * | 2001-02-08 | 2002-08-14 | 정장현 | Herbal composition for preventing and treating dementria |
JP2002238497A (en) * | 2001-02-19 | 2002-08-27 | Fancl Corp | Food composition |
-
2002
- 2002-09-23 KR KR1020020057658A patent/KR20040026273A/en not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970068894A (en) * | 1996-04-24 | 1997-11-17 | 강대일 · 정영숙 | Health food composition containing minerals, herbal medicine extracts and amino acids |
KR19990085202A (en) * | 1998-05-14 | 1999-12-06 | 김기영 | Herbal composition for the prevention and treatment of dementia |
JP2002119263A (en) * | 2000-10-16 | 2002-04-23 | Kazuhiro Kotani | Sport drink utilizing ocean deep water |
KR20020066173A (en) * | 2001-02-08 | 2002-08-14 | 정장현 | Herbal composition for preventing and treating dementria |
JP2002238497A (en) * | 2001-02-19 | 2002-08-27 | Fancl Corp | Food composition |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1773864A1 (en) * | 2004-07-31 | 2007-04-18 | Biogrand Co., Ltd. | Silk peptide improving neuroprotective and neurofunctional effects and a method of its preparation |
EP1773864A4 (en) * | 2004-07-31 | 2009-02-18 | Biogrand Co Ltd | Silk peptide improving neuroprotective and neurofunctional effects and a method of its preparation |
KR100856567B1 (en) * | 2006-10-11 | 2008-09-04 | 김명선 | Method for make of Health Supplement Food containing Wild Ginseng root cultivated powder |
KR20160129416A (en) | 2015-04-30 | 2016-11-09 | 부산대학교 산학협력단 | Medical herb tea therapy kit for improvement of cognitive ability |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69828881T2 (en) | COMPOSITION TO TREAT DISORDERS OF HUMAN HEALTH IN HEALTHY INDIVIDUALS | |
Ayoola et al. | Trace elements and major minerals evaluation of Spondias mombin, Vernonia amygdalina and Momordica charantia leaves | |
CN103461996A (en) | Toxin expelling, oxygenation and healthcare element capsule | |
CN102327541A (en) | Intensified snake-honeybee nano-selenium and germanium element capsule | |
CA2990533A1 (en) | A highly concentrated seawater mineral extract and uses thereof | |
CN111558031B (en) | Pure plant multifunctional eye special nutrient solution and preparation method thereof | |
KR20040026273A (en) | The health-supporting food being effective the dementia and its preparation method | |
KR100475196B1 (en) | The health-supporting food being effective the hairloss preventation or hair-growth and its preparation method | |
KR100486961B1 (en) | The health-supporting food being effective the sexual energy strength and its preparat ion method | |
DE60124516T2 (en) | COMBINATION OF THE LEZITHINE WITH ASCORBIC ACID | |
KR100486963B1 (en) | The health-supporting food having the effect of diabetes mellitus and its preparation method | |
KR100526639B1 (en) | The health-supporting food having the effect of anti-tumor and its preparation method | |
KR20190044862A (en) | Composition comprising ethanol extract of Aster scaber for preventon or treatment of neuropathic pain | |
KR100486960B1 (en) | The health-supporting food being effective the hypertension and its preparation method | |
KR101509056B1 (en) | Composition having brain function and congnition enhancing activity comprising ginseng mixed herbal extracts, ginsenoside Rg2 and ginsenoside F2 | |
KR100475197B1 (en) | The health-supporting food being effective the riddance of stress and its preparation method | |
CN105012688A (en) | Traditional Chinese medicine ointment used for treating keratosis pilaris, and preparation method thereof | |
CA2776919C (en) | Nutraceutical composition that comprises extract of shilajit, folic acid, vitamin b12 and vitamin b6 and the use thereof for preventing and/or treating neurodegenerative diseases and/or the cognitive deterioration associated with cerebral ageing | |
CN110123982A (en) | A kind of application of tsaoko essential oil | |
Sanjay et al. | Elementals Profile of Traditional Some Important Medicinal Plants of Uttarakhand State, India | |
KR20040003719A (en) | The health-supporting food being effective for diet and its preparation method | |
KR20040003720A (en) | The health-supporting food being effective for treatment of constipation and its preparation method | |
CN108464416A (en) | Natural toxin-expelling anti-oxidation health beverage | |
KR102448962B1 (en) | Manufacturing method of hypermineral ionized water, hypermineral ionized water manufactured by the same and cosmetic composition for skin keratin comprising the same | |
CN107308235A (en) | A kind of Chinese medicine composition and preparation method for preventing and treating chicken coccidiasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |